Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. - Wikidata - wikimedia - TriplyDB

Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.

Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.

http://www.wikidata.org/entity/Q39112927

about

Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.Innate immunity to Mycobacterium tuberculosis.Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment.Establishment of Elevated Serum Levels of IL-10, IL-8 and TNF-β as Potential Peripheral Blood Biomarkers in Tubercular Lymphadenitis: A Prospective Observational Cohort Study Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis.Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis Enhanced expression of interleukin-1alpha and tumor necrosis factor receptor-associated protein 1 in ileal tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis.Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation Lack of Association Between the IL1B (-511 and +3954), IL1RN VNTR Polymorphisms and Tuberculosis Risk: A Meta-analysis.Adipose Tissue in HIV Infection.Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces soluble tumor necrosis factor receptor production through tumor necrosis factor alpha-converting enzyme activation Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.A new parameter in the detection of tuberculosis activity: reactive oxygen metabolites.Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis.Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.

P2860

Q24816509-B6F612F7-31E9-42CD-923D-3CDFE7AD0F58 Q28396491-75A3CD1B-B23C-4B0D-8AB5-4996F8B66375 Q33711805-234A1FD4-F70E-49F6-9DE0-B974594C7563 Q33787988-4A748E8E-33AE-429A-873C-FDF633A5F5BC Q34001584-88427263-E559-44D2-BEC6-62CB18F7CEA4 Q34587177-11523874-D4F7-45CF-B4B1-43A0EE1DECDF Q34731357-4343179D-0C51-4667-8794-B9B114270C5A Q35099600-F4730BCC-4CC9-42E7-BFA2-D78082C47325 Q35897756-13ED2F56-DD2D-48A5-A129-8EBACDE51CBC Q35937184-2727DC88-43A1-4225-9975-3597C7983252 Q35976624-37087D7F-0404-4574-BB83-7A007325D755 Q36090847-4C52F4C6-E706-4782-BFA0-CD6C4FBC9988 Q36367874-BE268808-C65F-4F4A-8050-2798E7870D1A Q36376371-25D40229-31A4-4195-842D-CD34ACE21592 Q37518463-A13835A3-B690-4D05-9C3F-0927038F7188 Q38578576-A230D2D1-6B90-4EA3-B385-777E1400E3A7 Q40038736-BAC85876-E088-4417-BC5A-C283CC45CE65 Q41585430-7E741BE9-7FD4-4D6A-A605-91EE11803FEE Q41920055-A7317EAB-FC78-4D22-836B-F34A13607D1E Q46264440-CB2FA8EF-5790-4925-B3D1-1532B385C0F7 Q47816118-6EFDA8E6-D18A-4C42-AE2A-FBA77A89A0E9 Q51772061-2DEE05DE-AB98-4919-8DBF-57CA264B6128 Q51838282-0AFE97A2-CEF9-4838-81D4-6CC7EA2CBAD0 Q53854725-D0CBD6C4-94E0-4151-AB6A-7AF755E0A0BE

P2860

Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.

http://www.wikidata.org/entity/Q39112927

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@en

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@nl

type

label

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@en

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@nl

prefLabel

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@en

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@nl

P1433

Q39112927-235B6A65-5BE4-4865-B622-011E2E3B7204

P1476

Q39112927-1602E890-2793-4562-A89F-6F74DA40B1DF

P2093

Q39112927-802D5C2C-3439-4A49-B38E-EEA0C936E9A5

Q39112927-D00CDB62-1D73-459A-B367-CFF37C146FD1

Q39112927-D07DEB2E-F872-4BF2-B82D-11D8F9716D83

Q39112927-D34AFD37-878D-439F-9A80-32902B02D028

Q39112927-E338374F-2BD6-43E9-946E-7075373947E7

Q39112927-EF47D0C3-E951-4251-9430-5FE76C47E36E

P2860

Q39112927-05B6A217-D0FE-42E9-A1C0-8B6AD2329CE2

Q39112927-2F88D426-211B-43FD-9C72-5FA572CEEAC7

Q39112927-4C789BD9-04D2-4B8F-8DE9-2F97D8B4C5F9

Q39112927-67952035-F1C6-4C36-BAD9-463418D6EDEE

Q39112927-7FA360D8-3BE3-4DD1-9DB1-6585E3AD04BF

Q39112927-AF95C246-1629-487A-B182-545FFA6A3B1A

Q39112927-D070DBB7-3D38-4676-9CBA-36B3514364C2

Q39112927-EFB12503-A08C-4F05-96C7-97DBB83083D6

P304

Q39112927-81B5D648-EA9B-48EB-B01A-19EA0E767503

P31

Q39112927-CFCDDBFB-90C5-4053-9A40-154E55EF672A

P356

Q39112927-977DEE27-D366-41B6-A4F9-0E7EBDD6D227

P407

Q39112927-AF717955-473E-4A16-B48D-2E6CF365CE5D

P433

Q39112927-DEC21893-33DA-4410-A753-9BF1CC987502

P478

Q39112927-20012117-1F21-4444-88D5-DA23566E136B

P577

Q39112927-D47931AE-9BAC-4CDB-AC03-AA6F28C2125E

P698

Q39112927-509671F8-D0DF-43CF-8E04-D1D996F0FA64

P921

Q39112927-CB036842-4CD6-4FBC-AB9E-BF13D479B738

P356

AJRCCM.157.4.9709126

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Tumor necrosis factor and inte ...... ease activity of tuberculosis.

@en

P2093

Juffermans NP

http://www.w3.org/2001/XMLSchema#string

Speelman P

http://www.w3.org/2001/XMLSchema#string

Verbon A

http://www.w3.org/2001/XMLSchema#string

van Deutekom H

http://www.w3.org/2001/XMLSchema#string

van Deventer SJ

http://www.w3.org/2001/XMLSchema#string

van der Poll T

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis.

The protective immune response to Mycobacterium tuberculosis.

In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis.

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-1 Receptor Type II, IL-10, and IL-13

P304

1328-1331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.157.4.9709126

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9563758

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde